Search This Blog

Wednesday, December 24, 2008

"(Lumigan) is an effective IOP-lowering agent in patients with uveitic glaucoma in whom the uveitis is controlled on immunomodulatory therapy, and it does not increase the rate of flares of uveitis in these patients."